Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
The mechanisms by which estrogens improve glucose homeostasis are not completely understood.
Read More »Type 2 Diabetes Delayed by Menopause Hormone Therapy
Pain Medications in Newly Diagnosed DPN
How often are opioids being initiated for diabetic peripheral neuropathy (DPN) in newly diagnosed patients?
Read More »Using Albuminuria To Predict CV and Renal Outcomes For T2D
The association between 1-year changes in albuminuria and subsequent risk of cardiovascular and renal events.
Read More »Correlation Between Chronic Kidney Disease Progression and Cerebral Vascular Disease Outcomes in Type 2 Diabetes
Results of an extensive retrospective study indicate a strong association between glomerular filtration (eGFR) rate and cardiovascular disease morbidity rate.
Read More »More Stringent HbA1C Targets for Children and Adolescents with Type 1 Diabetes
What do the new ADA guidelines have to say about treating children and adolescents with type 1 diabetes?
Read More »Diabetes, Depression, and Dementia Link
The diagnosis and treatment of depression in the elderly population with type 2 diabetes are essential for managing dementia risks.
Read More »Using Semaglutide and Liraglutide To Protect the Kidney?
A two-for-one deal: both cardiovascular benefits and renal protection.
Read More »DKA Leads to Changes in Children’s Cognitive Function
Just one incident of DKA could potentially damage memory in children with type 1 diabetes.
Read More »Glycemic and Adiposity Benefits with Metformin Use in Pregnancy
A placebo-controlled trial was conducted to determine fetal, neonatal, and maternal outcomes associated with metformin use during pregnancy in women with T2DM.
Read More »Left Ventricular Mass Reduction and Empagliflozin
Empagliflozin significantly lowered LVMi, systolic blood pressure, and diastolic blood pressure in patients with CAD and type 2 diabetes.
Read More »